Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 108992415 | 10899241 | 5 | F | 201412 | 20160826 | 20150309 | 20160831 | EXP | US-PFIZER INC-2015080606 | PFIZER | 9.00 | YR | M | Y | 32.00000 | KG | 20160831 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 108992415 | 10899241 | 1 | PS | RAPAMUNE | SIROLIMUS | 1 | 0.25 MG, 1X/DAY, (LIQUID) | 21110 | .25 | MG | QD | ||||||||
| 108992415 | 10899241 | 2 | SS | RAPAMUNE | SIROLIMUS | 1 | Oral | 0.3 MG, LIQUID ONCE A DAY | 21110 | .3 | MG | QD | |||||||
| 108992415 | 10899241 | 3 | SS | REVATIO | SILDENAFIL CITRATE | 1 | 20 MG, 3X/DAY | 21845 | 20 | MG | FILM-COATED TABLET | TID | |||||||
| 108992415 | 10899241 | 4 | SS | REVATIO | SILDENAFIL CITRATE | 1 | 20 MG, 3X/DAY | 21845 | 20 | MG | FILM-COATED TABLET | TID | |||||||
| 108992415 | 10899241 | 5 | C | LETAIRIS | AMBRISENTAN | 1 | Oral | 5 MG, 1X/DAY | 0 | 5 | MG | TABLET | QD | ||||||
| 108992415 | 10899241 | 6 | C | LASIX | FUROSEMIDE | 1 | 10 MG, 2X/DAY, (LIQUID) | 0 | 10 | MG | BID | ||||||||
| 108992415 | 10899241 | 7 | C | REMODULIN | TREPROSTINIL | 1 | Subcutaneous | 0.028 NG PER KILOGRAM | 0 | ||||||||||
| 108992415 | 10899241 | 8 | C | VANCOMYCIN | VANCOMYCIN | 1 | 125 MG, 2X/DAY | 0 | 125 | MG | BID | ||||||||
| 108992415 | 10899241 | 9 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | UNK, 4X/DAY | 0 | QID | ||||||||||
| 108992415 | 10899241 | 10 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | UNK, AS NEEDED | 0 | |||||||||||
| 108992415 | 10899241 | 11 | C | FLOVENT | FLUTICASONE PROPIONATE | 1 | UNK, AS NEEDED | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 108992415 | 10899241 | 1 | Liver transplant |
| 108992415 | 10899241 | 3 | Pulmonary hypertension |
| 108992415 | 10899241 | 5 | Pulmonary hypertension |
| 108992415 | 10899241 | 6 | Pulmonary hypertension |
| 108992415 | 10899241 | 7 | Pulmonary hypertension |
| 108992415 | 10899241 | 8 | Clostridium difficile infection |
| 108992415 | 10899241 | 9 | Asthma |
| 108992415 | 10899241 | 10 | Asthma |
| 108992415 | 10899241 | 11 | Asthma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 108992415 | 10899241 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 108992415 | 10899241 | Clostridium difficile infection | |
| 108992415 | 10899241 | Diarrhoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 108992415 | 10899241 | 1 | 200506 | 0 | ||
| 108992415 | 10899241 | 2 | 2006 | 0 | ||
| 108992415 | 10899241 | 3 | 200512 | 0 | ||
| 108992415 | 10899241 | 4 | 2006 | 0 | ||
| 108992415 | 10899241 | 5 | 20160531 | 0 | ||
| 108992415 | 10899241 | 6 | 201504 | 0 | ||
| 108992415 | 10899241 | 7 | 201504 | 0 | ||
| 108992415 | 10899241 | 8 | 201601 | 0 |